Latest filings (excl ownership)
8-K
Regulation FD Disclosure
4 Apr 24
8-K
Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
6 Mar 24
25-NSE
Exchange delisting
21 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Feb 24
8-K/A
Cost Associated with Exit or Disposal Activities
24 Jan 24
8-K
Invitae Completes Sale of Reproductive Health Assets to Natera
22 Jan 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
8-K/A
Cost Associated with Exit or Disposal Activities
11 Jan 24
8-K
Cost Associated with Exit or Disposal Activities
14 Dec 23
8-K
Entry into a Material Definitive Agreement
11 Dec 23
8-K
Departure of Directors or Certain Officers
17 Nov 23
8-K
Departure of Directors or Certain Officers
15 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Invitae Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
Departure of Directors or Certain Officers
19 Oct 23
8-K
Departure of Directors or Certain Officers
27 Sep 23
8-K
Invitae Receives Notice of Non-Compliance with NYSE
22 Sep 23
8-K
Entry into a Material Definitive Agreement
23 Aug 23
8-K
Departure of Directors or Certain Officers
14 Aug 23
424B2
Prospectus for primary offering
10 Aug 23
424B2
Prospectus for primary offering
10 Aug 23
EFFECT
Notice of effectiveness
10 Aug 23
EFFECT
Notice of effectiveness
10 Aug 23
POS AM
Prospectus update (post-effective amendment)
9 Aug 23
POS AM
Prospectus update (post-effective amendment)
9 Aug 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Invitae Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
6 Jun 23
8-K
Departure of Directors or Certain Officers
25 May 23
8-K
Other Events
16 May 23
10-Q
2023 Q1
Quarterly report
9 May 23
8-K
Invitae Reports First Quarter 2023 Financial Results
9 May 23
8-K
Departure of Directors or Certain Officers
28 Apr 23
424B3
Prospectus supplement
24 Apr 23
EFFECT
Notice of effectiveness
24 Apr 23
ARS
2022 FY
Annual report to shareholders
19 Apr 23
DEFA14A
Additional proxy soliciting materials
19 Apr 23
DEF 14A
Definitive proxy
19 Apr 23
Latest ownership filings
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Nikko Asset Management Americas, Inc.
13 Feb 24
SC 13G/A
Sumitomo Mitsui Trust Holdings, Inc.
5 Feb 24
SC 13G/A
ARK Investment Management LLC
29 Jan 24
SC 13G/A
BlackRock Inc.
29 Jan 24
4
Robert L Nussbaum
21 Dec 23
4
Thomas Brida
21 Dec 23
4
David Sholehvar
14 Nov 23
3
David Sholehvar
14 Nov 23
4
Thomas Brida
20 Oct 23
4
Ana J. Schrank
2 Oct 23
3
Ana J. Schrank
2 Oct 23
4
Robert M. Guigley
25 Sep 23
3
Robert M. Guigley
14 Sep 23
SC 13G
Flynn James E
30 Aug 23
3
Robert IV Dickey
17 Aug 23
3
Jeff Parsons
11 Jul 23
144
Notice of proposed sale of securities
3 Jul 23
4
Robert L Nussbaum
15 Jun 23
4
Thomas Brida
15 Jun 23
4/A
Yafei Wen
24 May 23
4
Kenneth D. Knight
18 May 23
4
Robert L Nussbaum
18 May 23
4
Yafei Wen
18 May 23
4
ROBERT F. WERNER
18 May 23
4
Thomas Brida
18 May 23
4
Randal W. Scott
1 May 23
4
Geoffrey Crouse
1 May 23
4
Kimber D Lockhart
1 May 23
4
William H Osborne
1 May 23
4
Christine Marie Gorjanc
1 May 23
4
ERIC AGUIAR
1 May 23
4
Chitra Nayak
1 May 23
4
Robert L Nussbaum
5 Apr 23
4
Kenneth D. Knight
5 Apr 23
4
ROBERT F. WERNER
5 Apr 23
4
Yafei Wen
5 Apr 23
4
Thomas Brida
5 Apr 23
4
Thomas Brida
15 Mar 23
4
Robert L Nussbaum
15 Mar 23